REZWAN ISLAM: Open Payments
NPI 1124054556 · FULTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,205 in 81 payments from 16 companies in 2025. Trend: 2023 $1,152 · 2024 $1,188 · 2025 $1,205
Food & beverage: $1,205
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 29 | $426 |
| Novo Nordisk Inc | 18 | $198 |
| ABBVIE INC. | 10 | $165 |
| Dexcom, Inc. | 5 | $118 |
| Amgen Inc. | 3 | $43 |
| Phathom Pharmaceuticals, Inc. | 3 | $38 |
| Lilly USA, LLC | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| Axsome Therapeutics, Inc. | 2 | $29 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $23 |
Products named: NURTEC ODT, Dexcom G6 Transmitter, PREVNAR 20, Wegovy, QULIPTA, VRAYLAR, OTEZLA, Ozempic.
Industry payments across MO — which companies pay providers there.
